Skip to main content
. 2022 Dec 9;4(2):258–271. doi: 10.34067/KID.0001582022

Figure 3.

Figure 3

The glomerular diseases seen with immune checkpoint inhibitors. CTLA-4, cytotoxic T lymphocyte–associated protein-4; DC, dendritic cell; MCD, minimal change disease; PD-1, programmed cell death protein-1; PD-L1, programmed cell death protein–associated ligand-1; TCR, T cell receptor.